Announced Fri, 15 May · 21:03 IST

Krishna Institute of Medical Sciences Limited has informed the Exchange about change in Management

Promoter Family Board EntryManagement Changes View source PDF

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹766.00
prior close
₹748.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.2+0.3+0.2-3.4-2.3+0.5-1.0-1.6+2.4+2.0+3.1+3.3
Up moveDown movePending
AI summary

Krishna Institute of Medical Sciences Limited announced three key changes at its Board meeting on May 15, 2026. First, M/s Sagar & Associates, Cost Accountants, were appointed as Cost Auditors for FY 2026-27. Second, three Senior Management Personnel were appointed: Mr. Sachin Ashok Salvi as Chief Finance Officer (Chartered Accountant with 21 years experience, previously at Thyrocare Group), Mrs. Nagajayanthi J.R as Company Secretary & Compliance Officer (Fellow Member of ICSI with 25+ years experience), and Mr. Bhaskar Reddy R.K as Chief Risk Officer & Chief Internal Audit (Chartered Accountant with 12 years experience including roles at Deloitte and BDO). Third, Mr. Adwik Bollineni was re-designated from Non-Executive Director to Executive Director. Notably, Mr. Adwik Bollineni is the son of Dr. B. Bhaskara Rao (CMD) and brother of Dr. Abhinay Bollineni (Director & CEO), indicating a promoter family member entering executive leadership.

Likely market impact

The appointment of a qualified CFO with IPO experience and the elevation of a promoter family member to Executive Director signals strengthened financial management and continued family involvement in operations. This could be viewed positively for governance continuity but raises some governance considerations given the related-party nature of the director appointment.